Indian J Med Microbiol Close
 

Figure 3: Percentage of cases receiving neoadjuvant chemotherapy by histology by year. There was a linear increase in percentage receiving neoadjuvant chemotherapy for urothelial histology across years. For the other histologies, the increase was more irregular. This is likely due to small n, which leads to increased error in the estimate of percentage neoadjuvant chemotherapy. In general, neuroendocrine histology had higher percentage neoadjuvant chemotherapy than other histologies

Figure 3: Percentage of cases receiving neoadjuvant chemotherapy by histology by year. There was a linear increase in percentage receiving neoadjuvant chemotherapy for urothelial histology across years. For the other histologies, the increase was more irregular. This is likely due to small <i>n</i>, which leads to increased  error in the estimate of percentage neoadjuvant chemotherapy. In general, neuroendocrine histology had higher percentage neoadjuvant chemotherapy than other histologies